Search research articles
Contact Us
Filters
Showing results (91-100 of 175) with videos related to
Page
of 18
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1991
Growth factors and lymphokines: modulators of cholinergic neuronal activity
R Quirion, D M Araujo, P A Lapchak, et al.
Analytical Chemistry
|
February 1, 2007
In vivo electrochemical detection of nitric oxide in tumor-bearing mice
Sophie Griveau, Charlotte Dumézy, Johanne Séguin, et al.
Leukemia & Lymphoma
|
July 1, 1995
Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy
V Ribrag, L Massaad, F Janot, et al.
European Journal of Medicinal Chemistry
|
November 30, 2010
Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues
Martin Arthuis, Renée Pontikis, Guy G Chabot, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice
G G Chabot, M C Bissery, T H Corbett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouse
G G Chabot, D Branellec, A Sassi, et al.
Biology of the Cell
|
January 1, 1989
Internalization of atrial natriuretic peptide by adrenal glomerulosa cells
G Morel, P Mesguich, J G Chabot, et al.
The New England Journal of Medicine
|
October 1, 1998
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
F H Glorieux, N J Bishop, H Plotkin, et al.
European Journal of Medicinal Chemistry
|
June 1, 2012
In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4
Núria Mur Blanch, Guy G Chabot, Lionel Quentin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients
D Abigerges, G G Chabot, J P Armand, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 175) with videos related to
Sort By:
Page
of 18
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1991
Growth factors and lymphokines: modulators of cholinergic neuronal activity
R Quirion, D M Araujo, P A Lapchak, et al.
Analytical Chemistry
|
February 1, 2007
In vivo electrochemical detection of nitric oxide in tumor-bearing mice
Sophie Griveau, Charlotte Dumézy, Johanne Séguin, et al.
Leukemia & Lymphoma
|
July 1, 1995
Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy
V Ribrag, L Massaad, F Janot, et al.
European Journal of Medicinal Chemistry
|
November 30, 2010
Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues
Martin Arthuis, Renée Pontikis, Guy G Chabot, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice
G G Chabot, M C Bissery, T H Corbett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouse
G G Chabot, D Branellec, A Sassi, et al.
Biology of the Cell
|
January 1, 1989
Internalization of atrial natriuretic peptide by adrenal glomerulosa cells
G Morel, P Mesguich, J G Chabot, et al.
The New England Journal of Medicine
|
October 1, 1998
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
F H Glorieux, N J Bishop, H Plotkin, et al.
European Journal of Medicinal Chemistry
|
June 1, 2012
In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4
Núria Mur Blanch, Guy G Chabot, Lionel Quentin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients
D Abigerges, G G Chabot, J P Armand, et al.
Page
of 18